Bert M. Berla, PhD

Chief Science Officer
Bacterioscan, Inc

Disclosure(s): Bacterioscan, Inc.: Ownership Interest, Stocks/Bonds (Private Company)

Poster(s):

• (P-1561) Use of BacterioScan 216Dx to Reduce Antibiotic Use for Suspected Urinary Tract Infection in the Emergency Department
  Friday, October 18, 2024

  12:15 PM – 1:30 PM US PT